Wegovy Side Effects in Week 3: What to Expect and What to Do

Is what you're feeling in week 3 a reason to stop, or a reason to wait?

The decision most people face around week three isn't dramatic. It's quieter than that: should I push through this nausea, or is something actually wrong? Framing it as a binary choice (quit or carry on) misses a third option, which is to adjust how you're eating and drinking and let the prescriber know what's happening. That's the decision this page is built around.

Semaglutide's effect on the gut is pharmacological, not incidental. It slows how quickly food leaves your stomach, and at week three most people are still at the 0.25 mg dose. The NHS semaglutide medicines page lists nausea, vomiting, diarrhoea, constipation, indigestion and fatigue as common side effects, particularly in the early weeks of treatment. Common means they affect more than one person in ten. They're real, they're uncomfortable, and for the majority of people they do ease.

What tends to make week three harder than week one or two is the accumulation effect: you've had the discomfort for nearly a month and it hasn't disappeared yet. Eating smaller meals, avoiding fatty or heavily spiced food, sitting upright after eating, and sipping water steadily through the day all make a measurable difference in practice. What doesn't help: skipping meals to avoid nausea, then eating a large portion when hunger finally arrives.

If your symptoms are tolerable, adjusting your habits and giving it a little more time is a reasonable approach. If they're affecting your ability to eat or drink at all, that warrants a conversation with a prescriber before your next scheduled dose.

The side effects that should make you act today, not tomorrow

Most of what people experience in week three falls into the manageable category. A few things don't, and it's worth being clear about them.

Severe stomach pain that doesn't ease and radiates toward the back, with or without vomiting, is the pattern associated with acute pancreatitis. This is a known, though infrequent, side effect of GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically flagging pancreatitis as a serious risk with this class of medicine. The advice: stop eating, seek urgent medical attention, and do not wait to see if the pain settles on its own.

Signs of gallbladder problems (severe pain in the upper right abdomen, sometimes with fever or yellowing of the skin) also need same-day assessment. Gallstones are more likely to form during significant weight loss, and GLP-1 medicines are associated with a modest increased risk.

Dehydration from persistent vomiting or diarrhoea can progress faster than people expect. Dry mouth, dizziness on standing, and very dark urine are signals to rehydrate actively and get medical advice if they don't improve quickly. Kidney function can be affected by severe dehydration.

Allergic reactions (swelling around the face, throat or tongue, difficulty breathing, rapid heartbeat) are rare but serious. Treat them as an emergency.

If you're ever unsure whether something warrants urgent attention, NHS 111 is available by phone or online around the clock.

How what you do now shapes the weeks ahead

Week three sits right in the middle of the first titration period. Most prescribers move the dose from 0.25 mg to 0.5 mg after four weeks, provided side effects are manageable. If they're not, staying longer at the starting dose is clinically reasonable. Pushing the dose up when GI symptoms are already significant tends to amplify rather than shorten the discomfort.

Two practical points worth noting here. First, the injection site matters. Rotating between the abdomen, thigh and upper arm reduces localised reactions. Injecting into the same spot repeatedly causes tissue changes that can affect absorption. Second, alcohol tends to worsen nausea on semaglutide and contributes to dehydration; even a moderate amount early in treatment can make a difficult week worse.

If you're currently on Wegovy through a prescriber (including through a service like ours at nume) contacting your aftercare team with a clear account of your symptoms is the right first step, not a Google search for whether your experience is normal. A prescriber can decide whether to adjust your approach, pause the dose, or simply reassure you. For anyone who hasn't yet started treatment but is weighing up the early experience of semaglutide against tirzepatide, our Wegovy side effects overview and the weight-loss treatment overview give a fuller picture to take into that conversation.

The week four experience is often where the tide starts to turn for most people, which is worth knowing when week three feels like the worst of it. Looking back at how week two compared can also help you gauge whether things are improving, stable, or genuinely worsening. Our prescribers discuss side effects and individual suitability as part of every consultation, and if you want a fuller picture of how Wegovy works as a treatment before that conversation, including how the dose titration is designed to reduce early discomfort, that's a good place to start. If you found the side effects in week one harder to read about than to live through, you're not alone, and understanding that pattern can help put week three in context. Many people also find it useful to revisit what the first week of side effects typically looks like as a reference point for judging whether what they're experiencing now is a continuation of the same pattern or something new. Start your free consultation and speak to a named prescriber, not a chatbot.